| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,072 |
33,286 |
$2.66M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
42,026 |
37,918 |
$2.26M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
15,961 |
14,160 |
$1.20M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
11,517 |
10,836 |
$911K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25,709 |
23,770 |
$853K |
| 87631 |
|
6,160 |
5,802 |
$583K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,322 |
2,173 |
$173K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,411 |
2,007 |
$125K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,136 |
4,528 |
$112K |
| 99460 |
|
1,510 |
1,204 |
$106K |
| 99051 |
|
6,888 |
6,240 |
$87K |
| 87428 |
|
3,407 |
3,077 |
$83K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,012 |
12,593 |
$75K |
| D0145 |
Oral evaluation for a patient under three years of age |
2,212 |
2,112 |
$69K |
| D1206 |
Topical application of fluoride varnish |
3,217 |
3,045 |
$65K |
| 92551 |
|
8,048 |
7,333 |
$58K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
3,598 |
3,235 |
$52K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,800 |
1,668 |
$52K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
455 |
412 |
$35K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,566 |
1,466 |
$34K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,044 |
953 |
$27K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
723 |
643 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
413 |
343 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,072 |
2,720 |
$21K |
| 96127 |
|
7,843 |
6,662 |
$20K |
| 99462 |
|
622 |
498 |
$20K |
| 83655 |
|
1,938 |
1,804 |
$19K |
| 87400 |
|
1,669 |
693 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
456 |
401 |
$17K |
| 96161 |
|
7,617 |
6,960 |
$16K |
| 87420 |
|
1,629 |
1,442 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,471 |
1,247 |
$15K |
| 99173 |
|
7,468 |
6,781 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
6,362 |
5,524 |
$10K |
| 99490 |
Ccm add 20min |
1,831 |
1,592 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
932 |
686 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
59 |
52 |
$6K |
| 86308 |
|
1,114 |
991 |
$4K |
| 90686 |
|
5,215 |
4,647 |
$3K |
| 80305 |
|
287 |
245 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
320 |
264 |
$3K |
| 87807 |
|
218 |
192 |
$3K |
| 96160 |
|
1,211 |
1,075 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
30 |
28 |
$2K |
| 80061 |
Lipid panel |
159 |
143 |
$899.12 |
| 90461 |
|
16,482 |
15,558 |
$849.66 |
| 0001A |
|
28 |
28 |
$820.63 |
| 90670 |
|
8,380 |
7,989 |
$801.88 |
| 90677 |
|
890 |
819 |
$766.05 |
| 81003 |
|
442 |
372 |
$538.05 |
| 0002A |
|
14 |
13 |
$461.93 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
87 |
85 |
$342.30 |
| 80053 |
Comprehensive metabolic panel |
106 |
96 |
$283.71 |
| 99439 |
|
365 |
318 |
$234.29 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
143 |
137 |
$208.60 |
| 90619 |
|
80 |
77 |
$156.11 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
240 |
215 |
$156.01 |
| 90656 |
|
125 |
123 |
$117.04 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
158 |
127 |
$77.79 |
| 90707 |
|
1,890 |
1,774 |
$70.81 |
| 90715 |
|
73 |
68 |
$65.58 |
| 36416 |
|
9,919 |
8,788 |
$64.50 |
| 90723 |
|
6,644 |
6,296 |
$0.02 |
| 90680 |
|
3,298 |
3,140 |
$0.01 |
| 3077F |
|
152 |
120 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
244 |
230 |
$0.00 |
| 90633 |
|
2,957 |
2,751 |
$0.00 |
| 90681 |
|
1,344 |
1,253 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
108 |
86 |
$0.00 |
| 3078F |
|
822 |
640 |
$0.00 |
| 99080 |
|
45 |
45 |
$0.00 |
| 90700 |
|
248 |
218 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
51 |
50 |
$0.00 |
| 90671 |
|
550 |
381 |
$0.00 |
| 90380 |
|
33 |
25 |
$0.00 |
| 90687 |
|
32 |
30 |
$0.00 |
| 90734 |
|
45 |
42 |
$0.00 |
| 90685 |
|
48 |
45 |
$0.00 |
| 90647 |
|
6,200 |
5,837 |
$0.00 |
| 90651 |
|
196 |
179 |
$0.00 |
| 3074F |
|
1,180 |
931 |
$0.00 |
| 90716 |
|
1,851 |
1,732 |
$0.00 |
| 3079F |
|
513 |
403 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
716 |
642 |
$0.00 |
| 3075F |
|
199 |
147 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
31 |
28 |
$0.00 |
| 90381 |
|
57 |
44 |
$0.00 |
| 90696 |
|
122 |
118 |
$0.00 |
| 1036F |
|
174 |
148 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
75 |
68 |
$0.00 |
| 3080F |
|
100 |
73 |
$0.00 |
| 90688 |
|
14 |
12 |
$0.00 |